Sign Up Today and Learn More About Cytogel Pharma Stock
Invest in or calculate the value of your shares in Cytogel Pharma or other pre-IPO companies through EquityZen's platform.
Cytogel Pharma Stock (CYPH)
Cytogel Pharma is a bio-pharmaceutical development company that pursues strategic opportunities for pharmaceutical product development.
About Cytogel Pharma Stock
Founded
2000
Headquarters
Darien, CT, US
Total Funding
5.1M
Industries
Software, Artificial Intelligence, Data and Analytics
Cytogel Pharma Press Mentions
Stay in the know about the latest news on Cytogel Pharma
Novel Therapeutic Uses of Mu-Opiate Receptor Peptides
patents • Feb 10, 2025
Materials and Methods for Treatment of Inflammation
patents • Feb 10, 2025
Polymer agonists of mu opioid receptors
patents • Feb 10, 2025
Advantageous salts of mu-opiate receptor peptides
patents • Feb 10, 2025
Open Letter from Dean Maglaris, CEO of Cytogel Pharma
einpresswire • Feb 03, 2025
Cytogel Pharma Management
Leadership team at Cytogel Pharma
CEO
C. Dean Maglaris
Licensing and Business Development
James J. Hamsher
Join now and verify your accreditation status to gain access to:
- Cytogel Pharma Current Valuation
- Cytogel Pharma Stock Price
- Cytogel Pharma Management
- Available deals in Cytogel Pharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Cytogel Pharma Cap Table and Funding History by Share Class and Liquidity Preferences
- Cytogel Pharma Revenue and Financials
- Cytogel Pharma Highlights
- Cytogel Pharma Business Model
- Cytogel Pharma Risk Factors
- Cytogel Pharma Research Report from SACRA Research
Trading Cytogel Pharma Stock
How to invest in Cytogel Pharma stock?
Accredited investors can buy pre-IPO stock in companies like Cytogel Pharma through EquityZen funds. These investments are made available by existing Cytogel Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cytogel Pharma stock?
Shareholders can sell their Cytogel Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
